Long-term treatment outcome of Castleman’s disease: A real-world experience

BackgroundCastleman disease (CD), classified as unicentric CD (UCD) or multicentric CD (MCD), is a rare non-neoplastic lymphoproliferative disorder of unknown origin. Owing to its rarity, the clinical characteristics, therapeutic modalities, treatment outcomes, and prognostic factors related to UCD...

Description complète

Détails bibliographiques

Auteurs principaux:	Gi-June Min, Young-Woo Jeon, Tong Yoon Kim, Dae Hun Kwag, Jong Hyuk Lee, Joon Yeop Lee, Sung-Soo Park, Silvia Park, Jae-Ho Yoon, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Hee-Je Kim, Chang-Ki Min, Jong Wook Lee, Seok-Goo Cho
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2022-08-01
Collection:	Frontiers in Oncology
Sujets:	Castleman disease interleukin-6 age splenomegaly siltuximab steroids
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fonc.2022.974770/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!